What is the appropriate management for Ebstein anomaly?

Management of Ebstein Anomaly

All patients with Ebstein anomaly should be managed at specialized congenital heart disease centers with lifelong surveillance, and surgical intervention by expert congenital heart surgeons is recommended when symptoms develop, cyanosis occurs (oxygen saturation <90%), or progressive right ventricular dysfunction is detected 1.

Initial Diagnostic Evaluation

Every patient requires comprehensive baseline assessment including:

• ECG, chest x-ray, and transthoracic echocardiography-Doppler (Class I) 2
• Exercise stress testing with oxygen saturation monitoring to unmask occult exercise intolerance, as many patients underestimate their functional limitations 1, 3
• Holter monitoring for arrhythmia detection 2
• Electrophysiology study if supraventricular arrhythmia is documented or suspected, or if ECG shows evidence of accessory pathways 2

Echocardiography must specifically document:

• Degree of apical displacement of septal tricuspid leaflet (>8 mm/m² confirms diagnosis) 2
• Severity of tricuspid regurgitation and right ventricular dysfunction
• Presence of atrial septal defect or patent foramen ovale
• Assessment of left ventricular function 2

Cardiac MRI is increasingly recommended for reliable volumetric assessment of both ventricles, quantification of tricuspid regurgitation fraction, and detection of myocardial fibrosis 3.

Medical Management

Anticoagulation

Warfarin anticoagulation is mandatory (Class I) for patients with:

• History of paradoxical embolism
• Atrial fibrillation 2

Arrhythmia Management

Approximately one-third of adults with Ebstein anomaly have ventricular preexcitation, often with multiple accessory pathways, creating high sudden cardiac death risk 4.

Catheter ablation is beneficial (Class IIa) for recurrent supraventricular tachycardia, though success rates are lower than in structurally normal hearts (75-89% acute success with 25-30% recurrence) due to multiple pathways in up to 50% of patients 1. All patients suspected of having accessory pathways should undergo electrophysiology study before surgical repair to localize pathways and attempt ablation 1.

Beta-blockers or sotalol can be useful for preventing recurrent atrial tachycardia or flutter 5.

Heart Failure Management

Diuretics may reduce peripheral edema in right-sided heart failure but will not improve fatigue and dyspnea related to low left-sided cardiac output 2. The onset of peripheral edema typically reflects advanced right ventricular dysfunction and should prompt surgical consideration 1.

Surgical Indications

Class I Indications for Surgery (by expert congenital heart surgeons)

Surgery is recommended when ANY of the following are present:

1. Symptoms or deteriorating exercise capacity 1
2. Cyanosis (oxygen saturation <90%) 1
3. Paradoxical embolism 1
4. Progressive cardiomegaly on chest x-ray 1
5. Progressive RV dilation or reduction of RV systolic function 1

Critical point: Data demonstrate that delaying surgery until heart failure or RV systolic dysfunction develops is associated with poorer outcomes; surgery before either develops is strongly recommended 4. This is because Ebstein anomaly represents not just valve disease but a myopathic process, and the diseased right ventricle has limited capacity to tolerate volume loading.

Surgical Components

Primary operation typically includes:

• Tricuspid valve repair (preferred when feasible) or replacement with mechanical or bioprosthetic valve 1
• Closure of any interatrial communications 1
• Arrhythmia procedures: surgical division of accessory pathways, cryoablation, or Maze procedure 1
• Right reduction atrioplasty 1

Cone reconstruction has emerged as the preferred repair technique, achieving near-anatomic restoration of tricuspid valve anatomy with promising early and intermediate results 6.

Special Surgical Considerations

Concomitant arrhythmia surgery (Class I) is indicated for:

• Appearance/progression of atrial/ventricular arrhythmias not amenable to percutaneous treatment 1
• Ventricular preexcitation not successfully treated in electrophysiology laboratory 1
• Paroxysmal or continuous atrial fibrillation (Maze procedure reasonable) 3

Bidirectional cavopulmonary anastomosis (Glenn shunt) is considered when:

• Severe RV dysfunction with preserved LV function and low left atrial pressure 1
• Severe RV dilation, severe RV systolic dysfunction, or RA:LA pressure ratio >1.5 3
• Failure to separate from cardiopulmonary bypass after repair 3

Recent data show concomitant Glenn procedure significantly reduces risk of both reoperation (HR=0.160) and medical intervention (HR=0.259) 7.

Heart transplantation is considered when:

• Significant LV dysfunction (ejection fraction <30%) with important heart failure symptoms 1

Reoperation Indications (Class I)

Surgical rerepair or replacement is recommended for:

1. Symptoms, deteriorating exercise capacity, or NYHA class III-IV 1
2. Severe TR after repair with progressive RV dilation, reduced RV function, or arrhythmias 1
3. Bioprosthetic valve dysfunction with significant mixed regurgitation and stenosis 1
4. Predominant bioprosthetic stenosis (mean gradient >12-15 mmHg) 1

Note that tricuspid valve rerepair is rarely successful; replacement is usually required 1.

Outcomes

Early mortality is approximately 5-10% in experienced centers 1. Late survival is favorable at 92% at 10 years postoperatively, with similar survival after reoperation (80% at 15 years) 1. Freedom from reoperation rates are 97.95% at 5 years, declining to 83.22% at 20 years, though freedom from medical intervention shows progressive decline to 62.31% at 20 years 7.

Critical Pitfalls to Avoid

• Do not close ASD/PFO percutaneously without recognizing Ebstein anomaly, as the presence of Ebstein's may alter intervention recommendations 1
• Exercise caution with percutaneous ablation in patients with right-to-left shunt due to paradoxical embolus risk 1
• Multiple accessory pathways should raise suspicion for Ebstein anomaly 1
• Do not rely on symptoms alone—exercise testing is essential as patients with marked cardiomegaly may report few symptoms despite severe limitation 1
• Monitor oxygen saturation during exercise as exercise-induced cyanosis may occur 1
• Do not misdiagnose pulmonary hypertension—cyanosis and right-sided enlargement in Ebstein's is usually not PAH 1
• Tricuspid valve replacement carries high risk of complete AV block, especially in less experienced centers 1

Long-term Follow-up

All patients (operated and unoperated) require lifelong specialized surveillance for:

• Recurrent native tricuspid valve dysfunction after repair
• Prosthetic valve degeneration after replacement
• Atrial and ventricular arrhythmias
• Ventricular dysfunction 1

Preoperative risk factors for worse outcomes include:

• Hepatic congestion (HR=3.042)
• Wolff-Parkinson-White syndrome (HR=3.463)
• Elevated ALT levels (HR=1.023) 7

Patients requiring interventions show significantly worse physical and emotional quality-of-life scores, emphasizing the importance of timely surgical intervention guided by preoperative risk stratification 7.